Stem cell conjunctival transplantation for prevention of recurrence and film stability in advanced pterygium

To study the efficacy of stem cell conjunctival transplantation in prevention of recurrence and its effect on improvement of tear film stability in cases of advanced pterygium. 14 eyes of 14 patients with advanced pterygium were treated by excision followed by stem cell conjunctival graft transplantation. Follow up for recurrence and tear film stability was done for at least 6 months after surgery. All patients showed improved breakup time of tear film. None of the patients showed any evidence of recurrence. Only one patient [7.1%] had conjunctival recurrence. Stem cell conjunctival transplantation seems very effective in prevention of recurrence as well as improvement of tear film stability in treating patients with advanced pterygium

Photodynamic therapy with verteporfin for choroidal neovascularization in patients with pathologic myopia

To evaluate the safety and efficiency of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in patients with pathologic myopia. 12 eyes with subfoveal choroidal neovascularization secondary to pathologic myopia underwent photodynamic therapy with verteporfin. Visual acuity testing, full ophthalmological examination, Color photography and fluorescein angiography were used to evaluate the results of either single or repeated injection. All patients were followed for one year. Photodynamic therapy with verteporfin was well tolerated in all myopic patients. At end of the study, nine eyes [75%] showed either stability or improvement of one line in Snellen's chart. Photodynamic therapy with verteporfin generally achieved short-term cessation of or decrease in fluorescein leakage from subfoveal neovascularization without loss of vision in myopic patients